Drug
Lai Plus Multi Drug Regimen
Lai Plus Multi Drug Regimen: highest development phase Phase 2, developed by Insmed. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAI plus multi-drug regimen NCT03038178 | Phase 2 | Mycobacterium Infections, Nontuberculous |
Latest
No recent events.
Follow Lai Plus Multi Drug Regimen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.